Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group Shiyitang Pharmaceutical is a major subsidiary of the Harbin Pharmaceutical Group (Hayao), specializing in the development and manufacture of Traditional Chinese Medicine (TCM). The company operates under the historic Shiyitang brand, which was established in 1903 and is recognized as a Time-honored Brand in China. Its extensive product portfolio includes TCM decoction pieces, oral liquids, capsules, and tablets targeting respiratory, cardiovascular, and digestive health. Shiyitang integrates traditional herbal formulations with modern pharmaceutical manufacturing standards, maintaining multiple GMP-certified production facilities. The company is a key player in the Chinese domestic TCM market and contributes significantly to the parent group's diversified healthcare offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Pharmaceutical Group Traditional Chinese Medicine.